Skip to Content


Filter by:



Second Opinion

Learn about policy issues important to medical schools and teaching hospitals, with Executive Vice President Atul Grover, M.D., Ph.D.

Washington Highlights

HRSA Releases Proposed Rule Delaying Implementation of 340B Ceiling Price Requirements

May 4, 2018—The Health Resources and Services Administration (HRSA) released a proposed rule delaying the implementation of the 340B Drug Pricing Program ceiling price and manufacturer civil monetary penalties final rule to July 1, 2019. The regulation was initially set to take effect on March 6, 2017, but HRSA has delayed implementation of this final regulation numerous times, with the latest implementation date of July 1, 2018 [see Washington Highlights, Sept. 29, 2017]. 

The final rule, published in the Jan. 2, 2017 Federal Register (82 Fed. Reg. 1210), sets forth the calculation of the ceiling price and application of civil monetary penalties, and applies to all drug manufacturers that are required to make their drugs available to covered entities under the 340B program. The provisions of this final rule were initially set to take effect on March 6, 2017.

HRSA will accept stakeholder comments on this proposal until May 22. 

Contact:

Mary Mullaney
Director, Hospital Payment Policies
Telephone: 202-909-2084
Email: mmullaney@aamc.org

.

envelope on a green background

Subscribe to Washington Highlights

RSS icon

Subscribe to RSS

Washington Highlights, a weekly electronic newsletter, features brief updates on the latest legislative and regulatory activities affecting medical schools and teaching hospitals.


Past Issues


For More Information

Jason Kleinman
Sr. Legislative Analyst, Govt. Relations
Telephone: 202-903-0806
Email: jkleinman@aamc.org